Εμφάνιση απλής εγγραφής

dc.creatorGourgoulianis K., Daniil Z., Athanasiou K., Rozou S., Bontozoglou V.en
dc.date.accessioned2023-01-31T07:44:02Z
dc.date.available2023-01-31T07:44:02Z
dc.date.issued2017
dc.identifier10.1089/jamp.2016.1363
dc.identifier.issn19412711
dc.identifier.urihttp://hdl.handle.net/11615/72644
dc.description.abstractBackground: Accurate prediction of the regional deposition of inhaled dry powders as a function of powder properties and breathing pattern is a long-term research goal for pulmonary drug delivery. In the present work, deposition along the respiratory tract of dry powders of Fluticasone propionate and Salmeterol is predicted. Methods: A one-dimensional particle transport and deposition model is used, whose novelty is in the treatment of the alveolar space of each airway generation as an efficient mixing chamber. This assumption has been supported by simulations and measurements during the last 20 years. The model is applied to two popular pulmonary tree geometries, to investigate the effect of particle size on localized deposition and to estimate the uncertainty due to variations in airway size. Results and Conclusions: Application of the model for the specific particle size distribution measured by a cascade impactor in the marketed product ELPENhaler, predicts the whole lung deposition (WLD), as well as the split between pulmonary (PU) and tracheobronchial (TB) deposition. Introduction in the model of modified particle size distributions with increased fractions of fine particles, indicates that the fine-particle dose is a satisfactory predictor of WLD but not of the PU/TB ratio. © 2017, Mary Ann Liebert, Inc.en
dc.language.isoenen
dc.sourceJournal of Aerosol Medicine and Pulmonary Drug Deliveryen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85038356524&doi=10.1089%2fjamp.2016.1363&partnerID=40&md5=e28650ea9a60916309279f38d9bf2e16
dc.subjectfluticasone propionateen
dc.subjectsalmeterolen
dc.subjectbronchodilating agenten
dc.subjectfluticasoneen
dc.subjectsalmeterol xinafoateen
dc.subjectaerosolen
dc.subjectArticleen
dc.subjectcontrolled studyen
dc.subjectlung alveolusen
dc.subjectmathematical modelen
dc.subjectparticle depositionen
dc.subjectparticle sizeen
dc.subjectphysical phenomenaen
dc.subjectpredictionen
dc.subjectsimulationen
dc.subjectcomputer simulationen
dc.subjectdrug delivery systemen
dc.subjectdry powder inhaleren
dc.subjectequipment designen
dc.subjecthumanen
dc.subjectinhalational drug administrationen
dc.subjectlungen
dc.subjectmetabolismen
dc.subjecttissue distributionen
dc.subjectuncertaintyen
dc.subjectAdministration, Inhalationen
dc.subjectAerosolsen
dc.subjectBronchodilator Agentsen
dc.subjectComputer Simulationen
dc.subjectDrug Delivery Systemsen
dc.subjectDry Powder Inhalersen
dc.subjectEquipment Designen
dc.subjectFluticasoneen
dc.subjectHumansen
dc.subjectLungen
dc.subjectParticle Sizeen
dc.subjectSalmeterol Xinafoateen
dc.subjectTissue Distributionen
dc.subjectUncertaintyen
dc.subjectMary Ann Liebert Inc.en
dc.titleApplication of a One-Dimensional Computational Model for the Prediction of Deposition from a Dry Powder Inhaleren
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής